Circulation SAP
Natural health product licensed in Canada
- Licence holder
- Nutritional Fundamentals for Health Inc.
- NPN or DIN-HM
- 80143707
- Status
- Active licence
- Licence date
- 28 August 2025
- Revision date
- 10 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Amaranthus dubius Extract : Matériel brut sec Dry plant equivalent : 5,000 mg Potency : 9 % Nitrate | 100 mg | Not calculated |
| Crataegus monogyna Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 mg Potency : 3.5 % Oligomeric proanthocyanidins | 75 mg | Not calculated |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 8,000 mg Potency : 36 % Anthocyanins | 80 mg | Not calculated |
| Mélange de concentré de tocophérols Source : Helianthus annuus - Graine | 0.9 mg AT | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 3,000 mg Potency : 24 % Flavonoid glycosides | 60 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Mélange de concentré de tocophérols Source : Helianthus annuus - Graine | 30 mg | Not calculated |
| Niacinamide Source : Niacinamide | 100 mg | Not calculated |
| Allium sativum Source : Allium sativum - Bulbe Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Salix alba Source : Salix alba - Écorce de jeune branche Extract : Matériel brut sec Extraction ratio : 11:1 Dry plant equivalent : 1,100 mg Potency : 15 % Salicin | 100 mg | Not calculated |
Non-medicinal ingredients
Poudre d'enveloppes d'Oryza sativa (Riz), Dioxyde de silicium, Eau purifiée, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Vitamin supplement. Allium sativum is traditionally used in Herbal Medicine to help relieve the symptoms associated with upper respiratory tract infections and catarrhal conditions such as nasal congestion/buildup of excess mucus. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Bilberry/Vaccinium myrtillus is used in Herbal Medicine to help relieve symptoms related to non -complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80143707
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.